CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), a 29-amino-acid peptide modified with a Drug Affinity Complex (DAC) that extends its biological half-life from minutes to several days
This has made KLOW relevant in research focused on inflammation control, tissue stress, and recovery support
Kempczinski said he only expects GLP-1 adoption to ramp up further, and as adoption grows, we know that consumers behavior changes. But were also seeing changes around maybe less snacking, changes in some of the beverages that they drink, less sugary drinks, Kempczinski said
Health Benefits, anti-inflammatory effects and better heart/cardiovascular health, is also an approved treatment for sleep apnea
But doctors can also use it for weight loss, even though the FDA hasnt approved it for this